brivaracetam April 12, 2017 brivaracetam Trade Name Orphan Indication Symtomatic myoclonus USA Market Approval USA USA Designation Date 2005-10-05 00:00:00 Sponsor UCB Pharma, Inc.;1950 Lake Park Drive;Smyra, Georgia, 30080
